TLN1 and systemic sclerosis: Additionally, talin1 primarily exerts its effects through integrin β1 and β5 in SSc.<h4>Conclusions</h4>Overexpressed talin1 is participated in skin fibrosis of SSc, and talin1 appears to be a potential new therapeutic target for SSc.